Unveiling difficult-to-treat rheumatoid arthritis: long-term impact of biologic or targeted synthetic DMARDs from the KOBIO registry

Abstract Background While the availability of biological or targeted synthetic disease-modifying anti-rheumatic drugs (b/tsDMARDs) has improved outcomes for rheumatoid arthritis (RA) patients, there remains a subset of individuals who fail to achieve low disease activity or remission despite multipl...

Descripció completa

Dades bibliogràfiques

Autors principals:	Ju-Yang Jung, Eunyoung Lee, Ji-Won Kim, Chang-Hee Suh, Kichul Shin, Jinhyun Kim, Hyoun-Ah Kim
Format:	Artigo
Idioma:	Inglês
Publicat:	BMC 2023-09-01
Col·lecció:	Arthritis Research & Therapy
Matèries:	Rheumatoid arthritis Difficult-to-treat Biologic therapy DMARDs
Accés en línia:	https://doi.org/10.1186/s13075-023-03165-w
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!